securing funds cell therapy

How to increase your chances of securing funds for your cell therapy

Are you seeking investment to further fund your cell therapy research and development? Or perhaps you are looking for finance in order to commercialise and gain market access? Whatever the motivation, Terrapinn’s Investor Forum can help you move your business forward, closer to those patients who need your therapy the most, but act now as time is running out to …

Europe, US, Transatlantic, Trade, Investment, Agreement, Generics

EU-US Transatlantic Trade and Investment Agreement (TTIP) Impact on the Generics Industry

At the World Generic Medicines Congress Europe 2014, Michel Mikail, Fresenius Kabi, gave a presentation on “EU-US Transatlantic Trade and Investment Agreement (TTIP) Impact on the Generics Industry”. Download and learn: EU-US Transatlantic Trade & Investment Partnership (TTIP) Intellectual Property Rights Other ongoing negotiations FTAs’ opportunities and challenges Download presentation  Found this interesting? Join us at the 9th annual World Generic Medicines Congress Europe, …

investment in cell therapies

Promising scale and market success for cell therapies after large financial injection

In a report released this week, by BCC Research, it was forecasted that the global market for stem cells (including cell therapies) is to reach US $10.6 billion in 2018. However with currently no medicines, based on stem cells, having yet received marketing authorisation from the EMA*, or the FDA*, how are we going to get there? In 2013, the stem cell …

New inward investment brings innovative cancer cell therapy to Scotland

“New inward investment brings innovative cancer cell therapy to Scotland supported by £500,000 Regional Selective Assistance Start-up biotechnology company, TC BioPharm Ltd (TCB), is announcing a strategic collaboration with MEDINET, a Tokyo-listed immuno-cell therapy company, to develop a novel treatment for various different types of cancer. MEDINET will exclusively license its innovative cell therapy technology to TC Biopharm for clinical …

Sun Pharma to acquire Ranbaxy

Sun Pharmaceutical Industries and Ranbaxy Laboratories have recently made an agreement to which Sun Pharma will acquire 100% of Ranbaxy in an all-stock transaction, meaning that Sun Pharma has effectively acquired Ranbaxy, a major player in Indian and US markets. Due to this acquisition, it creates the fifth-largest specialty generics company in the world and the largest pharmaceutical company in …

India’s Lupin queues up for a share of the biosimilar boom

Lupin is searching for partners to help bring it into the biosimilars market, aiming top-selling treatments with patents that are expiring soon. It already has 10 biosimilars products in development, with 5 in late-stage studies. Thus, it is looking for partners to help bring these products into the market. In addition to injectables for cancer and inflammatory disease, Lupin is …

Keynote: New Pharma Partnering & Investment Opportunities

We’re at the final stretch of the conference with the remaining keynote session, “New Pharma Partnering & Investment Opportunities with Ajith Kamath, Wheaton Little and Younghwa Kim. Ajith Kamath, Senior Director and Head, Strategic Research Partnerships, Pfizer India spoke about the latest opportunities for strategic research partnerships in drug discovery by presenting drug discovery collaboration models at Pfizer. In an …

Teva’s New CEO Moves Quickly on Dealmaking

Recently, pharmaceutical company Teva has been facing numerous challenges. These include expiring patents for their top drugs, strong labour opposition to plans for restructuring, conflict between the Board of Directors and Management which resulted in the CEO’s departure, and shareholder unrest. Eyal Desheh, the CFO, has said that they have to make smart deals and partnerships like how Teva has …

Inforgraphic: Innovation in Pharma 2013

Last week saw Deloitte publish it’s fourth annual report looking at the return on investment pharmaceutical companies are seeing in their research and development projects. The report, co-produced with Thomson Reuters, looks at the current state of development pipelines in 12 top life science companies, and calculates a projected financial return for their products in the late stages of the …

Video: How are Global Austerity Measures Impacting Pharma?

Since the global recession in 2008 and the Eurozone crisis in 2009, nations across the globe have been subject to austerity measures impacting upon everything, including the pharma industry. But what is the extent of this impact? We pose this question to several of our speakers from Evidence EU 2013 including: Sophie Murdoch, Alliance Life Sciences Brian Lovatt, Vision Healthcare …